I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
It is used and studied as a vasoprotective anti-inflammatory, anti-edematous and anti-nociceptive agent.1 It may be used to study its pharmacokinetics, safety and efficacy as a chemosensitizer and modulator of NF-κ B cell signaling
Cesare R. Sirtori. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol. Res. 2001, 44 (3), 183-193 .
Ferruccio Berti.; Claudio Omini.; Daniela Longiave. The mode of action of Aescin and the release of prostaglandins. Prostaglandins. 1977, 14 (2), 241-249 .
Hazard Statements: H302
Harmful if swallowed.
Precautionary Statements: P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Rinse mouth. Dispose of contents/container in accordance with local/regional/national/international regulations.